Clinical Trial Update: Safety and Efficacy of FT14 Conditioning for Allogeneic HSCT in Acute Myeloid Leukemia [Phase 2]

View source ↗

Summary

A Phase 2 trial is evaluating the safety and efficacy of FT14 conditioning for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• FT14 conditioning (FT14 conditioning regimen)

Snippet

Sponsor: Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia | Conditions: Acute Myeloid Leukaemia (AML), Hematopoietic Stem Cell Transplant (HSCT) | Phase 2 | Status: ACTIVE_NOT_RECRUITING